EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification and biophysical characterization of a novel domain-swapped camelid antibody specific for fentanyl

Joseph P Gallant, Dustin Hicks, Ke Shi, Nicholas H Moeller, Brooke Hoppe, Eric W Lake, Carly Baehr, Marco Pravetoni, Hideki Aihara, Aaron M LeBeau

Journal of Biological Chemistry · 2024

DOI: 10.1016/j.jbc.2024.107502 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Joseph P Gallant und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Fentanyl, Single-Domain Antibodies. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCRR NIH HHS, NCI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Opioid use disorders (OUD) and overdoses are ever-evolving public health threats that continue to grow in incidence and prevalence in the United States and abroad. Current treatments consist of opioid receptor agonists and antagonists, which are safe and effective but still suffer from some limitations. Murine and humanized monoclonal antibodies (mAb) have emerged as an alternative and complementary strategy to reverse and prevent opioid-induced respiratory depression. To explore antibody applications beyond traditional heavy-light chain mAbs, we identified and biophysically characterized a novel single-domain antibody specific for fentanyl from a camelid variable-heavy-heavy (VHH) domain phage display library. Structural data suggested that VHH binding to fentanyl was facilitated by a unique domain-swapped dimerization mechanism, which accompanied a rearrangement of complementarity-determining region loops leading to the formation of a fentanyl-binding pocket. Structure-guided mutagenesis further identified an amino acid substitution that improved the affinity and relaxed the requirement for dimerization of the VHH in fentanyl binding. Our studies demonstrate VHH engagement of an opioid and inform on how to further engineer a VHH for enhanced stability and efficacy, laying the groundwork for exploring the in vivo applications of VHH-based biologics against OUD and overdose.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FentanylSingle-Domain AntibodiesAnimalsHumansCamelidaeCamelids, New WorldAnalgesics, Opioid

Stichwörter der Autor:innen

antibodiescrystal structuredomain-swapped dimeropioid addictionoverdosesynthetic opioids

Substanzen

FentanylSingle-Domain AntibodiesAnalgesics, Opioid

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
  • Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
  • Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, Minnesota, USA.
  • Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington, USA.
  • Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington, USA; Center for Medication Development for Substance Use Disorders, University of Washington, Seattle,…
  • Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, Minnesota, USA. Electronic address: aihar001@umn.edu.

Förderung

  • NCRR NIH HHS
  • NCI NIH HHS
  • NIGMS NIH HHS
  • NIDA NIH HHS
  • NIH
  • Argonne National Laboratory
  • National Cancer Institute
  • National Institute on Drug Abuse

Zitieren

APA

Gallant, J. P., Hicks, D., Shi, K., Moeller, N. H., Hoppe, B., Lake, E. W., Baehr, C., Pravetoni, M., Aihara, H., & LeBeau, A. M. (2024). Identification and biophysical characterization of a novel domain-swapped camelid antibody specific for fentanyl. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.107502

Vancouver

Gallant JP, Hicks D, Shi K, Moeller NH, Hoppe B, Lake EW, et al. Identification and biophysical characterization of a novel domain-swapped camelid antibody specific for fentanyl. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.107502

BibTeX
@article{Gallant2024,
  author = {Gallant, Joseph P and Hicks, Dustin and Shi, Ke and Moeller, Nicholas H and Hoppe, Brooke and Lake, Eric W and Baehr, Carly and Pravetoni, Marco and Aihara, Hideki and LeBeau, Aaron M},
  title = {Identification and biophysical characterization of a novel domain-swapped camelid antibody specific for fentanyl},
  journal = {Journal of Biological Chemistry},
  year = {2024},
  doi = {10.1016/j.jbc.2024.107502}
}
Kostenlos starten →